Too many hurdles for drug industry to launch new products.

The common prescription drug list as regulated by the revised provision rather hampers the drug company smoothly to launch any new products into the market.

According to the revised provision, it takes quite a long process for any new drugs to book in the common prescription drug list, getting through so many district medical and pharmacy associations for final approval.

When the common p...